The IMCEPSYN brand, founded in 2014 (Sweden), from 585 sister brands and 17478 competing brands. The IMCEPSYN brand is owned by ASTRAZENECA, a company listed in London. Its International Securities Identification Number (ISIN) is GB0009895292. IMCEPSYN is part of the Drug Manufacturers activity sector.